Catheryn ORourke - Reckitt Benckiser Gen VP
RBGLY Stock | USD 12.32 0.13 1.07% |
Insider
Catheryn ORourke is Gen VP of Reckitt Benckiser Group
Phone | 44 17 5321 7800 |
Web | https://www.reckitt.com |
Reckitt Benckiser Management Efficiency
The company has return on total asset (ROA) of 0.0681 % which means that it generated a profit of $0.0681 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3931 %, meaning that it generated $0.3931 on every $100 dollars invested by stockholders. Reckitt Benckiser's management efficiency ratios could be used to measure how well Reckitt Benckiser manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Brenton JD | Beauty Health Co | 54 | |
Steve Austenfeld | Honest Company | N/A | |
Robert Long | Kimberly Clark | 67 | |
Asmita Dubey | LOral SA | 48 | |
Jennifer Rosenberg | Honest Company | N/A | |
Cindy Thomassee | European Wax Center | N/A | |
Emmanuel Goulin | LOral SA | N/A | |
Paul Parker | The Clorox | 57 | |
Sandi Karrmann | Kimberly Clark | N/A | |
Sandra Karrmann | Kimberly Clark | 58 | |
Mark Smucker | Kimberly Clark | 51 | |
Marc Prouve | Estee Lauder Companies | 58 | |
Michael Read | Church Dwight | 49 | |
JeanClaude Grand | LOral SA | 58 | |
Gavin OConnor | European Wax Center | 54 | |
Stephan Habif | Colgate Palmolive | N/A | |
Jacques Challes | LOral SA | 63 | |
Fabian Garcia | Unilever PLC ADR | 64 | |
Jeffrey Baker | The Clorox | N/A | |
Blake Roney | Nu Skin Enterprises | 65 | |
Sally Massey | Colgate Palmolive | 50 |
Management Performance
Return On Equity | 0.39 | |||
Return On Asset | 0.0681 |
Reckitt Benckiser Leadership Team
Elected by the shareholders, the Reckitt Benckiser's board of directors comprises two types of representatives: Reckitt Benckiser inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Reckitt. The board's role is to monitor Reckitt Benckiser's management team and ensure that shareholders' interests are well served. Reckitt Benckiser's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Reckitt Benckiser's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sami Naffakh, Chief Officer | ||
Filippo Catalano, Chief Officer | ||
Fabrice Beaulieu, Sustainability Marketing | ||
Ranjay Radhakrishnan, Chief Officer | ||
Kris Licht, Pres Officer | ||
Nicandro Durante, Independent Non-Executive Director | ||
Richard Joyce, Sr. VP of Investor Relations, Communications and External Affairs | ||
John Dawson, VP Relations | ||
BEng ACMA, Group Director | ||
Catheryn ORourke, Gen VP |
Reckitt Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Reckitt Benckiser a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.39 | |||
Return On Asset | 0.0681 | |||
Profit Margin | 0.22 % | |||
Operating Margin | 0.23 % | |||
Current Valuation | 61.62 B | |||
Shares Outstanding | 3.58 B | |||
Shares Owned By Institutions | 1.63 % | |||
Price To Earning | 31.16 X | |||
Price To Book | 4.76 X | |||
Price To Sales | 3.74 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Reckitt Pink Sheet Analysis
When running Reckitt Benckiser's price analysis, check to measure Reckitt Benckiser's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reckitt Benckiser is operating at the current time. Most of Reckitt Benckiser's value examination focuses on studying past and present price action to predict the probability of Reckitt Benckiser's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reckitt Benckiser's price. Additionally, you may evaluate how the addition of Reckitt Benckiser to your portfolios can decrease your overall portfolio volatility.